Flerie Completes Biosergen Merger, Issues 2.67 Million Shares
Flerie transferred all Biosergen assets and liabilities to Flerie as merger consideration. It issued 2,667,234 new shares, bringing share capital to SEK 196.6 million across 89,364,936 ordinary shares.